Patient-specific modeling of G2/M cell cycle dynamics reveals prognostic dynamical regimes driven by copy number alterations
{{output}}
Cell cycle dysregulation is a hallmark of cancer and a major source of tumor heterogeneity. While large-scale cancer genomics studies have characterized recurrent copy number alterations affecting cell cycle regulators, how these alterations translate into pat... ...
